Who is in your network?

Data Insights and Decision-Making: Leveraging Healthcare Analytical Testing Services Market

https://www.marketsandmarkets.....com/Market-Reports/h

The Healthcare analytical testing services Market is projected to reach a valuation of USD 7.4 billion in 2024, with an anticipated surge to USD 12.6 billion by 2029, exhibiting a CAGR of 11.2% throughout the forecast period. Growth in the Healthcare analytical testing services Market is mainly driven by factors such as Growing pharmaceutical and biopharmaceutical R & D activities, stringent regulatory requirements, rising number of clinical trials, growing focus on biosimilars and biologics and rising acceptance of QbD approach in pharma research and manufacturing. However, lack of skilled professionals and rising costs and market competition can negatively affect growth of the market during the forecast period.

The prominent players in the global healthcare analytical testing services market include Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), Element Materials Technology (UK), Thermo Fisher Scientific, Inc. (US), Pace Analytical Services LLC (US), Intertek Group plc (UK), IQVIA Inc. (US), Merck KGaA (Germany), Source BioScience (UK), Almac Group (UK), ICON Plc (Ireland), Frontage Laboratories, Inc. (US), STERIS Plc (US), Sartorius AG (Germany), ALS Life Science (US), Syneos Health, INC (US), Medpace Holdings, Inc. (US), LGC Limited (UK), Parexel International Corporation (US), Celerion (US). Pharmaron (China), and BioAgilytix Labs (US).

 

www.marketsandmarkets.com

Healthcare Analytical Testing Services Market Size And Global Industry Forecast 2029

The global size of healthcare analytical testing services market in terms of revenue was estimated to be worth $7.4 billion in 2024 and is poised to reach $12.6 billion by 2029, growing at a CAGR of 11.2% from 2024 to 2029.

Enhancing Accessibility: Strategies for Widening Mental Health Screening

https://www.marketsandmarkets.....com/Market-Reports/m

The Mental Health Screening market is projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, at a CAGR 12.2% from 2023 to 2029. Mental health screening refers to the process of assessing an individual’s mental health status to identify potential signs or symptoms of mental health conditions. It is a preliminary step in recognizing and addressing mental health concerns early on. The goal of mental health screening is to identify individuals who may be at risk of or experiencing mental health issues so that appropriate interventions, support, or further assessments can be provided.

 

www.marketsandmarkets.com

Mental Health Screening Market Size, Share, Trends and Revenue Forecast [Latest]

The global mental health screening market in terms of revenue was estimated to be worth $0.9 billion in 2023 and is poised to reach $1.8 billion by 2029, growing at a CAGR of 12.2% from 2023 to 2029.

Emerging Trends in Multiplex Assays: Market Insights

https://www.marketsandmarkets.....com/Market-Reports/m

The multiplex assays market is valued at an estimated USD 3.5 billion in 2022 and is projected to reach USD 5.3 billion by 2027, at a CAGR of 8.8%

Healthy Animals, Healthy Market: Trends in Veterinary API Industry

https://www.marketsandmarkets.....com/Market-Reports/v

The Global Veterinary API Market is projected to reach USD 11.9 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 6.9% the forecast period. There are several factors which drive the Veterinary API Market like rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures. The veterinary API industry is anticipated to develop because of the rising demand for veterinary medicines and other animal health products.

The market for Veterinary API Market is dominated by companies like Phibro Animal Health Corporation (US), Fabbrica Italiana Sintetici S.p.A. (Italy), Sequent Scientific Ltd. (India), Excel Industries Ltd. (India), NGL Fine-Chem Ltd. (India), Insud Pharma (Spain), Menadiona Sl (Spain), Rochem International Inc. (US), and Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. (China)

 

www.marketsandmarkets.com

Veterinary API Market Size, Share, Trends and Revenue Forecast, 2028 | MarketsandMarkets

The global veterinary API market in terms of revenue was estimated to be worth $8.5 billion in 2023 and is poised to reach $11.9 billion by 2028, growing at a CAGR of 6.9% from 2023 to 2028.

Overcoming Adhesion Challenges: Insights into the Market Landscape

https://www.marketsandmarkets.....com/Market-Reports/a

The global adhesion barrier market size is projected to reach USD 0.9 billion by 2028 from USD 0.7 billion in 2023, at a CAGR of 7.4% during the forecast period. The increasing volume of surgeries and sports-related injuries, rising geriatric population, and the increasing awareness about adhesion formation and adhesion-related diseases are the major factors driving the growth of this market. On the other hand, the reluctance towards the usage of adhesion barriers amongst surgeons is expected to restrain the growth of this market during the forecast period. The untapped emerging markets will offer lucrative opportunities to the companies offering in adhesion barrier market.

 

www.marketsandmarkets.com

Adhesion Barrier Market Size, Share, Trends and Revenue Forecast, 2028 | MarketsandMarkets

The global adhesion barrier market in terms of revenue was estimated to be worth $0.7 billion in 2023 and is poised to reach $0.9 billion by 2028, growing at a CAGR of 7.4% from 2023 to 2028.